Cargando…
Oridonin Delays Aging Through the AKT Signaling Pathway
Aging is a major risk factor for chronic diseases and disability in humans. Nowadays, no effective anti-aging treatment is available clinically. In this study, oridonin was selected based on the drug screening strategy similar to Connectivity MAP (CMAP) but upon transcriptomes of 102 traditional Chi...
Autores principales: | An, Yongpan, Zhu, Jie, Wang, Xin, Sun, Xinpei, Luo, Chunxiong, Zhang, Yukun, Ye, Yuwei, Li, Xiaowei, Abulizi, Abudumijiti, Huang, Zhizhen, Zhang, Hang, Yang, Baoxue, Xie, Zhengwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157590/ https://www.ncbi.nlm.nih.gov/pubmed/35662728 http://dx.doi.org/10.3389/fphar.2022.888247 |
Ejemplares similares
-
Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity
por: Li, Xiang, et al.
Publicado: (2021) -
Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses
por: Kadioglu, Onat, et al.
Publicado: (2018) -
Oridonin inhibits aberrant AKT activation in breast cancer
por: Sun, Bowen, et al.
Publicado: (2018) -
Jiyuan oridonin A induces differentiation of acute myeloid leukemia cells including leukemic stem-like cells
por: Li, Fahui, et al.
Publicado: (2022) -
Antiangiogenic effects of oridonin
por: Tian, Lili, et al.
Publicado: (2017)